Document Detail


Replacement of protease inhibitors by nevirapine or efavirenz in simplification and rescue interventions: which works better?
MedLine Citation:
PMID:  12916009     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The outcome of 162 patients replacing protease inhibitors (PIs) by nonnucleoside reverse transcriptase inhibitors (NNRTIs) was retrospectively assessed. After 48 weeks of follow-up, nevirapine (NVP) and efavirenz (EFV) performed similarly well in simplification interventions in patients with undetectable viremia, while EFV provided significantly better results in rescue interventions after PI failure. Previous suboptimal exposure to nucleoside analogs conditioned lower chances of virologic success using either NVP or EFV. Both drugs were generally well tolerated, although specific toxicities could make one drug more suitable than the other for certain patients.
Authors:
Pablo Barreiro; Nuria Camino; Rosa De Julián; Juan González-Lahoz; Vincent Soriano
Related Documents :
16767919 - Low-dose thalidomide plus monthly high-dose oral dexamethasone (thali-dexa): results, p...
22116079 - Biologicals and switch in rheumatoid arthritis throughout time - are we being more aggr...
22239899 - Imaging for planning of cardiac resynchronization therapy.
12553479 - Transient rebounds of low-level viraemia among hiv-infected patients under haart are no...
18788909 - Characterization of drug-resistance mutations in hiv type 1 isolates from drug-naive an...
22490399 - Three methods assess nutritional status of leukemia patients before hematopoietic stem ...
20470959 - Total ankle arthroplasty in the rheumatoid patient.
9400589 - Common cardiac diseases in adolescents.
9109739 - Startle responses in hereditary hyperekplexia.
Publication Detail:
Type:  Comparative Study; Journal Article    
Journal Detail:
Title:  HIV clinical trials     Volume:  4     ISSN:  1528-4336     ISO Abbreviation:  HIV Clin Trials     Publication Date:    2003 Jul-Aug
Date Detail:
Created Date:  2003-08-13     Completed Date:  2004-03-17     Revised Date:  2014-02-06    
Medline Journal Info:
Nlm Unique ID:  100936377     Medline TA:  HIV Clin Trials     Country:  United States    
Other Details:
Languages:  eng     Pagination:  244-7     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Benzoxazines
Female
HIV Infections / drug therapy*,  virology
HIV Protease Inhibitors / administration & dosage*,  adverse effects,  therapeutic use*
HIV-1 / drug effects,  physiology
Humans
Male
Middle Aged
Nevirapine / administration & dosage*,  adverse effects,  therapeutic use*
Oxazines / administration & dosage*,  adverse effects,  therapeutic use*
Retrospective Studies
Reverse Transcriptase Inhibitors / administration & dosage,  adverse effects,  therapeutic use
Salvage Therapy*
Time Factors
Treatment Outcome
Chemical
Reg. No./Substance:
0/Benzoxazines; 0/HIV Protease Inhibitors; 0/Oxazines; 0/Reverse Transcriptase Inhibitors; 99DK7FVK1H/Nevirapine; JE6H2O27P8/efavirenz

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Compact quadruple therapy with the lamivudine/zidovudine combination tablet plus abacavir and efavir...
Next Document:  Sustained efficacy of nevirapine in combination with two nucleoside analogues in the treatment of HI...